Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma

This publication has 29 references indexed in Scilit:

• Phosphodiesterase inhibitors in airways disease
  European Journal of Pharmacology, 2006
• Therapeutic administration of Budesonide ameliorates allergen‐induced airway remodelling
  Clinical and Experimental Allergy, 2005
• Inhaled Glucocorticoids, Lymphocytes, and Dendritic Cells in Asthma and Obstructive Lung Diseases
  Proceedings of the American Thoracic Society, 2004
• Effects of phosphodiesterase inhibitors on interleukin-4 and interleukin-13 generation from human basophils
  British Journal of Pharmacology, 2004
• PDE4D plays a critical role in the control of airway smooth muscle contraction
  The FASEB Journal, 2003
• Inhibitor Binding to Type 4 Phosphodiesterase (PDE4) Assessed Using [3H]Piclamilast and [3H]Rolipram
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Increased surfactant protein D in rat airway goblet and Clara cells during ovalbumin‐induced allergic airway inflammation
  Clinical and Experimental Allergy, 2002
• Tumour necrosis factor‐α: The role of this multifunctional cytokine in asthma
  Immunology & Cell Biology, 2001
• What can we learn from murine models of asthma?
  Clinical and Experimental Allergy, 1999